Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 11/05/26
Aurora Cannabis Stock: What Organigram's Buyout Means for InvestorsZacks Investment Research • 11/04/26
ACB's Q2 Earnings on Deck: International Medical Cannabis in FocusZacks Investment Research • 10/27/26
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market ProgramPRNewsWire • 10/26/26
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future UpsidePRNewsWire • 10/14/26
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even HigherThe Motley Fool • 10/12/26
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease24/7 Wall Street • 10/08/26
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower OutputPRNewsWire • 10/08/26
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review UnderwayPRNewsWire • 10/06/26
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile BidPRNewsWire • 10/05/26
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.The Motley Fool • 09/26/26
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid DisclosurePRNewsWire • 09/23/26
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and BeyondPRNewsWire • 09/16/26
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsPRNewsWire • 09/14/26
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis BusinessPRNewsWire • 09/09/26